Grants for For Profit Organizations Other Than Small Businesses

To implement a project aimed at advancing U.S. foreign policy and national security priorities by supporting initiatives that make decision-making structures and processes in fragile, conflict, or crisis-affected contexts more reflective of and responsive to the needs and perspectives of partner states to ensure strategic trade control systems meet international standards and by engaging on bilateral, regional and multilateral levels with foreign governments to aid in the establishment of independent capabilities to regulate transfers of weapons of mass destruction, WMD-related items, conventional arms, and related dual-use items, and to detect, interdict, investigate, and prosecute illicit transfers of such items.

The New York State Department of Corrections and Community Supervision (DOCCS) invites applications from not-for-profit and for-profit providers for the development and operation of Community Based Residential Programs (CBRP) for individuals under Community Supervision. The CBRP is a housing initiative to assist parolees under the jurisdiction of DOCCS to attain stability in the community while providing for individual case needs and community safety. CBRPs provide food, counseling, and other services such as substance abuse treatment, educational/vocational training, mental health and social services to residents either directly or through referral to credentialed providers. (Note: a CBRP is not to be confused with Substance Use Residential Treatment Programs). To be eligible for an award, programs must have a current and valid Certificate of Occupancy (COO). For initial award, applicants must have the demonstrated ability to start the program on October 1, 2022, or upon approval by the Office of the State Comptroller (OSC). An approved site visit may be required by DOCCS within 10-days of a tentative contract award notification by the Commissioner.The components of this RFA are as follows:A CBRP provides a structured setting and services for a period of up to 120-days, withextensions available upon approval of DOCCS’ Re-Entry Contract Manager, to thefollowing client groups:Client Group A: Newly released parolees from state or local correctional facilities who do not have an acceptable residence.Client Group B: Parolees who require increased supervision and structure in order to change behavior patterns which, given case circumstances, may otherwise lead to re-incarceration; and/orrequire removal from their current living environment due to crisis situations or need for temporary housing.Client Group C: Parolees with mental health, physical and/or medical concerns.Client Group D: Parolees who have a history of sex offense(s) and/or arson.Many of the parolees have histories of chemical dependency, mental illness, unemployment, health concerns, and substandard housing. They are released from state or local incarceration after convictions for offenses for which they continue to serve a sentence that was imposed by a local County Court. They generally are returning to the communities where they were residing at the time of their arrest.DOCCS reserves the right to award more than one contract for a Catchment Area based on the need for residential programs that include Client Group D. DOCCS seeks to establish Community Based Residential Programs throughout New York State under the following general provisions and designated Catchment areas as listed in RFA 2021-02.

The U.S. Department of State, Bureau of Democracy, Human Rights, and Labor (DRL) announces an open competition for organizations interested in submitting applications for projects that support civil society in the Western Balkans to hold governments accountable and transparent by promoting greater public participation with a focus on environmental issues. The United Nations Environmental Programme held a Western Balkans Forum in late 2022 that concluded the region is heavily impacted by climate and pollution issues. Corruption and inconsistent implementation of regulations further exacerbate the situation. These environmental issues may be highly detrimental to communities in these countries, impacting the health of individuals and putting their rights to safe living conditions and access to natural resources at risk. For instance, a 2022 study from the Belgrade Centre for Security Policy cited instances of increased pollution in regions proximate to new development projects, which degraded air quality and local water sources, causing potential health risks to local communities including respiratory infections and autoimmune diseases. Activists have recounted how local politicians use fear of economic crisis to demotivate citizens from speaking out against industrial pollution. The lack of local good governance in tackling environmental challenges has catalyzed public discontent and distrust. There is a need for citizen advocacy to hold local 2 leaders accountable to environmental regulations, and to protect against egregious environmental damage. To address some of these issues and leverage civil society’s activism, DRL/GP is seeking proposals that promote greater public participation and ensure government transparency and accountability. The project will focus on environmental governance processes in Western Balkan countries with high levels of international economic influence. The program aims to: (1) support local communities and/or organizations to mobilize to advance good governance principles and their intersection with local environmental laws and regulations; (2) engage independent media and community members in monitoring and documenting cases of noncompliance with environmental policies; and (3) create a diverse network of reform advocates collaborating to build accountability for implementing current laws and development of rightsrespecting policies.

The United States Agency for International Development (USAID) plans to invest in a five-year cooperative agreement titled GH Social and Behavior Change (SBC) Activity to support countries in achieving desired improvements in health and development outcomes.The GH SBC Activity will build upon current USAID investments in SBC research and programming, including both global and bilateral projects, to guide integration of SBC evidence and theory in development programming, support generation and use of new learning, strengthen local technical and organizational capacity, and drive local leadership of SBC programming for better, broader, and more sustainable results. The project will fulfill a global leadership function within SBC, working through new and existing partnerships to create opportunities for locally-driven, innovative, and cost-effective SBC programs; systematic integration of SBC best practices within public and private health systems; and generating, synthesizing, and catalyzing the application of evidence-based and theory-informed SBC in diverse program settings to accelerate achievement of global health and development goals.The strategic objective of the project is to increase implementation of theory-informed, evidence-based, locally-led SBC programming. While focused primarily on health, the project may address SBC needs in other sectors, with particular attention to areas of potential complementarity such as environmental conservation, agriculture, food security, and nutrition. Within the health sector, the project will maintain a substantive but non-exclusive focus on family planning, reproductive health (FP/RH) and reproductive empowerment; malaria; and maternal, newborn, and child health (MNCH), with attention to emerging pandemic threats and other infectious diseases. Considerations of USAID priorities such as localization, gender integration, youth engagement/integration, health systems strengthening, the inclusion of LGBTQI+ people, the inclusion of people with physical and cognitive disabilities, engaging the voices, skills, and experiences of allincluding marginalized and underrepresented groups such as racial, ethnic, and Indigenous communities and climate change, will be a focus across the project.Please see the Full GH Social and Behavior Change (SBC) Activity RFA under the "Related Documents" tab.

The New York State Department of Labor (NYSDOL) is making up to $2 million in State Apprenticeship Expansion Formula (SAEF) funding available under the Direct Entry Pre-Apprenticeship Programs (DEPA) Request for Applications (RFA). The purpose of the RFA is to: 1. Provide funding for DEPA programs to support approximately 300 participants; and2. Support entry into NYS Registered Apprenticeship (RA) programs for underrepresented populations including women, minorities, individuals with disabilities, and veterans.NYSDOL is particularly interested in supporting DEPA programs that provide participants with training and exposure to various trades and offer opportunities for entry into RA training programs. Targeted industries include, but are not limited to, Building and Construction, Manufacturing, and Information Technology (IT).Although grantmaking activities will transition from the Grants Gateway to the Statewide Financial System (SFS) on January 16, 2024, applications for this funding opportunity will continue to be accepted through Grants Gateway until the submission deadline date of March 29, 2024.Note: With the transition of grantmaking activities from the Grants Gateway to SFS, prequalification will be unavailable from December 15, 2023 through January 16, 2024. After January 16, 2024, organizations will prequalify in SFS. If an organization is prequalified at the time of the cutover, their prequalification status will move over to SFS. Additional information regarding prequalification can be found at https://grantsmanagement.ny.gov/transition-SFS.

This program provides competitive funding for community organizations and local governments to build or improve public facilities that support work, education, and health monitoring in response to the COVID-19 pandemic.

The Louis Stokes Alliances for Minority Participation (LSAMP) program invests in the Nation's colleges and universities to aid student success to create a new generation of STEM discoverers for the national STEM enterprise. The program takes a comprehensive approach to the STEM Learning Ecosystem to impact STEM student development and retention. LSAMP is an alliance-based program, whereby a group of institutions of higher education (IHEs) work together to diversify the nation's science, technology, engineering, and mathematics (STEM) workforce by increasing the number of STEM baccalaureate and graduate degrees awarded to persons from LSAMP populations. LSAMP populations are defined as persons from groups underrepresented in the STEM enterprise: Blacks and African-Americans, Hispanic and Latino Americans, American Indians, Alaska Natives, Native Hawaiians, and Pacific Islanders. The LSAMP program provides funding to alliances that implement comprehensive, evidence-based, innovative, and sustained strategies that ultimately result in the graduation of well-prepared, highly competitive students from LSAMP populations who pursue graduate studies or careers in STEM, while also supporting knowledge generation, knowledge utilization, assessment of program impacts, dissemination activities and dissemination of scholarly research into the field. Projects supported by the LSAMP program include: --Alliance Development Grants (ADG) support the conceptualization and development of new B2B and new SPIO alliances. (New) --Bridge-to-the-Baccalaureate (B2B) alliances facilitate the successful transfer of students from LSAMP populations to four-year institutions in pursuit of STEM baccalaureate degrees. --STEM Pathways Implementation-Only (SPIO) alliances are designed for new and reconstituted alliances. These projects focus on building and strengthening strategies and approaches to assist Institutions of Higher Education (IHEs) increase STEM baccalaureate degrees to LSAMP populations and facilitate entry into STEM graduate degree programs. --STEM Pathways Research Alliances (SPRA) are designed for well-established alliances. These projects serve as models of excellence in STEM broadening participation by (1) steadily increasing STEM baccalaureate degrees to LSAMP populations and facilitating entry into STEM graduate degree programs; (2) producing and disseminating new scholarly research on the broadening participation of LSAMP populations (or underrepresented and underserved populations in STEM disciplines and the nation's STEM workforce) and, (3) holistically assess the state of institutionalization and sustainability of the alliance. --Bridge to STEM Graduate Degrees in National Priorities (BD-Master's) projects support cohorts of six graduate students pursuing a M. S. degree in STEM national priority areas, providing financial support (stipends and cost of education) and support to help develop and maintain academic and research skills that enable participants to successfully persist in STEM graduate degree programs at Master's comprehensive-degree producing institutions only. (New) --Bridge to STEM Graduate Degrees in National Priorities (BD-Doctoral) projects support cohorts of twelve graduate students pursuing a Ph.D. degree in STEM national priority areas, providing financial support (stipends and cost of education) and support to help develop and maintain academic and research skills that enable participants to successfully persist in STEM doctoral degree programs. --STEM Networking Incentives and Engagement (NETWORKS) projects provide support to incentivize the creation and participation of LSAMP populations in STEM networks. (New)

The NISTs Accelerating Federal Technology Transfer (AFTT) Program is seeking applications from eligible applicants for activities to help promote, educate, and facilitate federal technology transfer. Under the AFTT Program, members of the Federal Laboratory Consortiums (FLC) Executive Board, including NIST, will collaborate with the awardee on the development of outreach and educational programs, tools, and best practices that will enhance the ability of the academic and private sectors to engage with Federal laboratories in technology transfer and research commercialization. Specifically, the awardee will collaborate with the FLCs Executive Board, including NIST, in the areas of technology transfer and research commercialization by: developing the necessary tools and services to promote the utilization of Federal intellectual property, user facilities, and other R resources by non-federal partners; creating a suitable education and training infrastructure in technology transfer for the relevant stakeholders; and engaging industry, academic, and state and local government communities to facilitate access to federal R collaborations and federal technology transfer opportunities on both a regional and a national level.

The Clean Water Grant Program (CWGP), offered by the County of Cumberland, Pennsylvania, provides financial support for "shovel-ready" initiatives aimed at enhancing local water quality within Cumberland County. While the description doesn't explicitly state a "foundation mission alignment" or "foundation's strategic priorities and theory of change," it can be inferred that the program aligns with broader environmental stewardship and public health goals, likely stemming from the county's responsibility to manage and improve local resources. The program's core objective is to maximize the impact of limited pollution reduction funding by investing in priority water quality projects. The target beneficiaries of the CWGP are diverse, including non-profit 501(c) organizations, municipal governments, educational institutions, and businesses with headquarters in Cumberland County. The impact goals are directly tied to improving local water quality. The program focuses on developing a water quality project backlog to leverage additional funding, pursuing multifaceted pollution reduction strategies with various stakeholders, accelerating progress toward county pollution reduction goals, and institutionalizing an annual project identification process integrated into county CAP development plans. The priorities and focuses of the CWGP revolve around "shovel-ready" projects that deliver tangible water quality improvements. While there is no minimum or maximum grant award, projects with a local match will receive higher priority, indicating a preference for initiatives that demonstrate community investment and shared responsibility. The program anticipates approximately $500,000 will be available for subawards in 2025, with funding decisions at the sole discretion of Cumberland County and contingent upon PADEP approval. Expected outcomes and measurable results include enhanced local water quality, increased leveraging of additional government and nonprofit funding for water quality projects, a more coordinated approach to pollution reduction among various stakeholders, accelerated progress towards county-wide pollution reduction targets, and a sustainable, integrated annual process for identifying and developing water quality initiatives. The grant period for performance is from March 2025 to December 2025, emphasizing a focus on projects that can demonstrate impact within a relatively short timeframe.

This program provides financial assistance to Michigan's food and agriculture businesses to help them meet wastewater regulations and improve their infrastructure.

Initially created in FY09, the OCRP Ovarian Cancer Academy (OCA) is a unique, interactive virtual academy providing intensive mentoring, national networking, collaborations, and a peer group for junior faculty. The overarching goal of the OCA is to develop successful, highly productive ovarian cancer researchers in a collaborative research and career development environment.The OCA is a virtual career development and research training platform that consists of Early-Career Investigators (ECIs), their Designated Mentors from different institutions, and an Academy Dean and Assistant Dean. The OCA-ECI Award is not a traditional career development award; the ECI is expected to participate in monthly webinars and annual workshops and to communicate and collaborate with other members of the Academy (other ECIs, Mentors, the Dean and Assistant Dean) as well as with the advocacy community. Since its inception, the Academys ECIs have presented at and chaired sessions for ovarian cancer-specific symposia and served on symposia review committees. They have also served as peer reviewers for the Department of Defense (DOD) OCRP and other funding agencies.Pre-Application (Preproposal) Submission Deadline: 5:00 p.m. Eastern time (ET), May 14, 2024 • Invitation to Submit an Application: June 17, 2024 • Application Submission Deadline: 11:59 p.m. ET, August 6, 2024 • End of Application Verification Period: 5:00 p.m. ET, August 9, 2024 • Peer Review: October 2024 • Programmatic Review: December 2024

The FY24 OCRP Clinical Trial Translational Endpoints Research Award intends to support correlation of clinical trial-related data (e.g., biosample analysis, imaging, or epidemiological data) with clinical outcomes or responses to therapies. Correlative studies may be associated with a past, ongoing, or future clinical trial in order to associate various factors (genetic, DOD FY24 Ovarian Cancer Clinical Trial Translational Endpoints Research Award 4biochemical, environmental and others) with initiation, progression, metastasis, recurrence, prognosis, diagnosis or effect of intervention on ovarian cancer outcomes. The translational research should address high-impact or unmet needs in ovarian cancer. The proposed research may be hypothesis testing or may be designed to generate new hypotheses to be tested in follow-up clinical research. The award may not be used to directly support a clinical trial.

The PRMRP Technology/Therapeutic Development Award (TTDA) is a product-driven award mechanism intended to provide support for the translation of promising preclinical findings into products for clinical applications, including prevention, detection, diagnosis, treatment, or quality of life, for a disease or condition related to one of the FY24 PRMRP Topic Areas and one of the FY24 PRMRP Strategic Goals. Products in development should be responsive to the health care needs of military Service Members, Veterans, and their Families. The product(s) to be developed under the PRMRP TTDA mechanism may be a tangible item, such as a pharmacologic agent (drugs or biologics) or device, or a knowledge-based product. (A knowledge product is a non-materiel product that addresses an identified need in a topic area, is based on current evidence and research, aims to transition into medical practice, training, tools, or to support materiel solutions [systems to develop, acquire, provide, and sustain medical solutions and capabilities], and educates or impacts behavior throughout the continuum of care, including primary prevention of negative outcomes.)The Technology/Therapeutic Development Award is not intended for basic research. Applicants generating preliminary data, basic research, performing high-risk/high-gain studies should consider one of the other FY24 PRMRP program announcements being offered. For information about these award mechanisms, see Section II.A.1, FY24 PRMRP Research Development Pipeline.

The OCRP Pilot Award supports the exploration of innovative concepts or theories in ovarian cancer that could ultimately lead to critical discoveries or major advancements that will drive the field forward. The proposed research must demonstrate a clear focus on ovarian cancer (e.g., using tissues, cell lines, datasets, or appropriate animal models), and serve as a catalyst to expand or modify current thinking about and/or approaches in ovarian cancer. If cell lines or animals are to be used, a clear justification should be provided for the choice of proposed cell line(s) or animal model(s).

The OCRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of ovarian cancer. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first-in-human, phase 0) to demonstrate the feasibility or inform the design of more advanced trials through large-scale trials to determine efficacy in relevant patient populations.

The FY24 PRMRP Impact Award supports applied research, defined as use-inspired and practice-oriented science that brings together outcomes from basic research, and insights from the real-world environment, to foster clinical applicability. The intent of the Impact Award is to translate the fundamental understanding of underlying mechanisms toward practical applications that have the potential for major near-term impact on patients affected by one of the diseases and conditions included in the FY24 PRMRP Topic Areas.Proposed research should refine mature concepts and ideas into translatable solutions with a view toward evaluating technical feasibility of promising new pharmacological agents, knowledge products, behavioral and rehabilitation interventions, diagnostic and therapeutic techniques, clinical guidance, and/or emerging approaches and technologies. The FY24 PRMRP Impact Award is not intended to support basic research.For the purposes of this funding opportunity, basic research is defined as exploratory science directed toward greater knowledge or understanding of the fundamental aspects of phenomena or outcomes, without specific applications toward process and products. Examples include, but are not limited to, high-risk/high-gain approaches, mechanistic studies, and preliminary data generation/validation. Applicants seeking funding for research that meets this definition should consider one of the other FY24 PRMRP program announcements being offered. For information about these award mechanisms, see Section II.A.1, FY24 PRMRP Research Development Pipeline.Pre-Application (Letter of Intent) Submission Deadline: 5:00 p.m. Eastern time (ET), May 13, 2024

The PRMRP Discovery Award is intended to support innovative, untested, non-incremental, high-risk/potentially high-reward research that will provide new insights, paradigms, technologies, or applications. The proposed project may be exploratory, hypothesis-driven, or hypothesis-generating research but must be novel and must be based on a strong scientific rationale and a well-developed study design and plan of analysis. Studies supported by this award are expected to lay the groundwork for future avenues of scientific investigation or product development. The outcome of research supported by this award should be the generation of robust preliminary data that can be used as a foundation for groundbreaking future research projects.This award is not intended to support/validate ongoing research and inclusion of preliminary data is not allowed. Inclusion of preliminary data other than serendipitous finding is not consistent with the exploratory nature of this award. Applicants seeking funding for research to further an existing research project should consider one of the other FY24 PRMRP program announcements being offered. For information about these award mechanisms, see Section II.A.1, FY24 PRMRP Research Development Pipeline.

The FY24 VRP MCRA is intended to support patient-oriented vision injury research and develop research expertise of highly motivated military or civilian clinicians in training. Research supported by the MCRA can be a standalone study of high impact to vision injury care or the generation of clinical research data in preparation for a more expansive study.Each MCRA must be led by an established clinician or Ph.D. clinical scientist who will serve as Principal Investigator (PI) of the award. Key personnel must include a clinician in training (e.g., a fellow, resident, junior clinician, clinician in a Ph.D. program). The clinician in training should have sufficient time remaining in their training program to complete the research proposed under the MCRA. The clinician in training will conduct the proposed research under the mentorship of the PI, with support from supporting personnel as appropriate. While additional junior scientists or clinicians may participate in the research, only one clinician in training may be designated as mentee. A Letter of Organizational Support and Mentee Eligibility, signed by the Department Chair or appropriate organization official, and a Letter of Commitment, signed by the mentee, should be submitted as part of Attachment 2: Supporting Documentation.For the purposes of this award mechanism, clinical research is defined as research conducted with human subjects or research on material of human origin, such as tissues or specimens or data obtained from human subjects. Documentation of Institutional Review Board (IRB)/ Ethics Committee (EC) approval or exemption by December 1, 2024, is required for an MCRA application to be considered for funding. See Attachment 2: Supporting Documentation for additional detail.The MCRA may not be used to conduct preclinical research (including animal research) or clinical trials.A clinical trial is defined in the Code of Federal Regulations, Title 45, Part 46.102 (45 CFR 46.102) as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include a placebo or another control) to evaluate the effects of the interventions on biomedical or behavioral health-related outcomes.Studies that do not seek to measure safety, effectiveness, and/or efficacy outcome(s) of an intervention are not considered clinical trials.Studies that retrospectively analyze data generated from previously conducted clinical trial(s) are not considered a clinical trial.

The OCRP Investigator-Initiated Research Award is intended to support high-impact research that addresses a critical need and has the potential to make an important contribution to ovarian cancer or patient/survivor care. Research projects may focus on any phase of research, from basic laboratory research through translational research, excluding clinical trials. The application must demonstrate logical reasoning and a sound scientific rationale established through a critical review and analysis of the literature for the application to be competitive. Applications must include preliminary data that are relevant to ovarian cancer and support the proposed research project. These data may be unpublished or from the published literature.

The PRMRP Investigator-Initiated Research Award (IIRA) supports fundamental research studies that will make an important contribution toward research, patient care, and/or quality of life for a disease or condition related to one of the FY24 PRMRP Topic Areas and one of the FY24 PRMRP Strategic Goals. This award mechanism is intended to support basic research that is exploratory in nature and seeks to further or validate preliminary findings for short- or long-term impact. Research projects may focus on any stage of basic laboratory research, ranging from fundamental research for the generation of knowledge, hypothesis, or models, to expansion of mature data.The rationale for a research idea may be derived from a laboratory discovery, population-based studies, a clinicians first-hand knowledge of patients, or anecdotal data. The project should include a well-formulated testable hypothesis based on existing evidence. Applications must include relevant preliminary data that support the rationale and feasibility for the proposed study. These data may be unpublished or from the published literature.This award mechanism is not intended to support translational research. Applicants seeking funding for projects that have progressed beyond the realm of basic research should consider one of the other FY24 PRMRP program announcements being offered. For information about these award mechanisms, see Section II.A.1, FY24 PRMRP Research Development Pipeline.